These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7622833)

  • 1. The content and context of compliance.
    Bebbington PE
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 5():41-50. PubMed ID: 7622833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
    Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
    J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adherence to antipsychotic medication in schizophrenia patients].
    Baloush-Kleinman V; Poyurovsky M; Koren D; Schneidman M; Weizman A; Shnitt D
    Harefuah; 2002 Dec; 141(12):1042-9, 1090. PubMed ID: 12534202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
    Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
    Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of noncompliance in patients with schizophrenia.
    Perkins DO
    J Clin Psychiatry; 2002 Dec; 63(12):1121-8. PubMed ID: 12523871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of medication compliance in schizophrenia: empirical and clinical findings.
    Fenton WS; Blyler CR; Heinssen RK
    Schizophr Bull; 1997; 23(4):637-51. PubMed ID: 9366000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic alliance, a stake in schizophrenia].
    Charpentier A; Goudemand M; Thomas P
    Encephale; 2009 Feb; 35(1):80-9. PubMed ID: 19250998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Assessing beliefs and attitudes of relatives of patients with schizophrenia: a study in a Tunisian sample].
    Bouhlel S; Ben Haouala S; Klibi A; Ghaouar M; Chennoufi L; Melki W; El-Hechmi Z
    Encephale; 2013 Jun; 39(3):165-73. PubMed ID: 23095602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to antipsychotic medications.
    Perkins DO
    J Clin Psychiatry; 1999; 60 Suppl 21():25-30. PubMed ID: 10548139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication.
    Rettenbacher MA; Hofer A; Eder U; Hummer M; Kemmler G; Weiss EM; Fleischhacker WW
    J Clin Psychiatry; 2004 Sep; 65(9):1211-8. PubMed ID: 15367047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing medication use in schizophrenic patients.
    Diamond RJ
    J Clin Psychiatry; 1983 Jun; 44(6 Pt 2):7-14. PubMed ID: 6133855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Compliance in the treatment of schizophrenia--project ADHES (the renewed results)].
    Chadzyńska M; Meder J; Tyszkowska M
    Psychiatr Pol; 2008; 42(4):561-70. PubMed ID: 19189600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The meaning of antipsychotic medication to patients with schizophrenia.
    Seeman MV; Seeman N
    J Psychiatr Pract; 2012 Sep; 18(5):338-48. PubMed ID: 22995961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode.
    Perkins DO; Johnson JL; Hamer RM; Zipursky RB; Keefe RS; Centorrhino F; Green AI; Glick IB; Kahn RS; Sharma T; Tohen M; McEvoy JP; Weiden PJ; Lieberman JA;
    Schizophr Res; 2006 Mar; 83(1):53-63. PubMed ID: 16529910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the therapeutic alliance in the treatment of schizophrenia. Relationship to course and outcome.
    Frank AF; Gunderson JG
    Arch Gen Psychiatry; 1990 Mar; 47(3):228-36. PubMed ID: 1968329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment-resistant schizophrenia--the role of clozapine.
    Meltzer HY
    Curr Med Res Opin; 1997; 14(1):1-20. PubMed ID: 9524789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An economic review of compliance with medication therapy in the treatment of schizophrenia.
    Thieda P; Beard S; Richter A; Kane J
    Psychiatr Serv; 2003 Apr; 54(4):508-16. PubMed ID: 12663838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder.
    Byerly MJ; Fisher R; Carmody T; Rush AJ
    J Clin Psychiatry; 2005 Aug; 66(8):997-1001. PubMed ID: 16086614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.